- Kumagai Y, Fujita T, Maeda M, Yamamoto A, Amano H. Pharmacology and safety of TAS5315, a Bruton tyrosine kinase inhibitor, in healthy volunteers: First-in-human, randomized, ascending-dose studies. Br J Clin Pharmacol. 2025 Mar 14. doi: 10.1002/bcp.70039.
- Kuroda Y, Ito Y, Nishizawa N, Tanabe M, Goto T, amashita A, Hosono K, Satoh M, Kumamoto Y Hiki N, Amano H.Activation of Invariant Natural Killer T Cells Enhances Ischemia-Reperfusion Injury in Steatotic Mouse Livers. in vivo. 2025 (in press)
